These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 33733242)
1. An efficient and versatile CRISPR-Cas9 system for genetic manipulation of multi-drug resistant McConville TH; Giddins MJ; Uhlemann AC STAR Protoc; 2021 Mar; 2(1):100373. PubMed ID: 33733242 [TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae. Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854 [No Abstract] [Full Text] [Related]
3. Genome Editing in Klebsiella pneumoniae Using CRISPR/Cas9 Technology. Wang Z; Wang Y; Ji Q Methods Mol Biol; 2022; 2479():105-117. PubMed ID: 35583735 [TBL] [Abstract][Full Text] [Related]
4. Application of CRISPR/Cas9-Based Genome Editing in Studying the Mechanism of Pandrug Resistance in Klebsiella pneumoniae. Sun Q; Wang Y; Dong N; Shen L; Zhou H; Hu Y; Gu D; Chen S; Zhang R; Ji Q Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988149 [TBL] [Abstract][Full Text] [Related]
5. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum. Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843 [TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Wang Y; Wang Z; Ji Q STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078 [TBL] [Abstract][Full Text] [Related]
8. An adapted method for Cas9-mediated editing reveals the species-specific role of β-glucoside utilization driving competition between Almási ÉdH; Knischewski N; Osbelt L; Muthukumarasamy U; El Mouali Y; Vialetto E; Beisel CL; Strowig T J Bacteriol; 2024 Mar; 206(3):e0031723. PubMed ID: 38353529 [TBL] [Abstract][Full Text] [Related]
9. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance. Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872 [TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum. Jiang Y; Qian F; Yang J; Liu Y; Dong F; Xu C; Sun B; Chen B; Xu X; Li Y; Wang R; Yang S Nat Commun; 2017 May; 8():15179. PubMed ID: 28469274 [TBL] [Abstract][Full Text] [Related]
11. Expanding the Reach of Recombineering to Environmental Bacteria. Borrero-de Acuña JM; Poblete-Castro I Trends Biotechnol; 2020 Jul; 38(7):684-685. PubMed ID: 32312593 [TBL] [Abstract][Full Text] [Related]
12. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines. Gao P; Dong X; Wang Y; Wei GH STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225 [TBL] [Abstract][Full Text] [Related]
13. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799 [TBL] [Abstract][Full Text] [Related]
14. A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum. Wasels F; Jean-Marie J; Collas F; López-Contreras AM; Lopes Ferreira N J Microbiol Methods; 2017 Sep; 140():5-11. PubMed ID: 28610973 [TBL] [Abstract][Full Text] [Related]
15. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae. Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567 [TBL] [Abstract][Full Text] [Related]
16. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system. Farooq U; Notani D STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853 [TBL] [Abstract][Full Text] [Related]
17. Repurposing the Native Type I-F CRISPR-Cas System in Xu Z; Li Y; Yan A STAR Protoc; 2020 Jun; 1(1):100039. PubMed ID: 33111087 [TBL] [Abstract][Full Text] [Related]
18. Protocol for genetic engineering in Drosophila suzukii using microinjection. Yan Y; Schetelig MF STAR Protoc; 2024 Sep; 5(3):103248. PubMed ID: 39146186 [TBL] [Abstract][Full Text] [Related]